BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  TherapeuticsMD Announces Full Year 2024 Financial Results

  March 28, 2025

   · 

  4 min read
• Press Releases

  Lantern Pharma Provides Business Updates and Fourth Quarter & Year-End 2024 Financial Results

  March 28, 2025

   · 

  16 min read
• Press Releases

  Beta Bionics Announces Board Appointment of Gerard Michel

  March 28, 2025

   · 

  4 min read
• Press Releases

  Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

  March 28, 2025

   · 

  13 min read
• Press Releases

  Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

  March 28, 2025

   · 

  2 min read
• Press Releases

  Teva Releases Q1 2025 Aide Memoire

  March 28, 2025

   · 

  2 min read
• Press Releases

  TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138

  March 28, 2025

   · 

  6 min read
• Press Releases

  SNBL and Tasso, Inc. to Establish Joint Venture in Japan

  March 28, 2025

   · 

  2 min read
• Press Releases

  Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

  March 28, 2025

   · 

  6 min read
• Press Releases

  InnoCare Announces First Patient Dosed in the Phase III Registrational Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Treatment of CLL/SLL Patients in China

  March 28, 2025

   · 

  2 min read